drugs in pediatrics
TRANSCRIPT
5/16/2018 Drugs in Pediatrics - slidepdf.com
http://slidepdf.com/reader/full/drugs-in-pediatrics 1/18
Drugs in Pediatrics NMT11
www.MedadTeam.org 1
Respiratory
TBTBTBTB
TreatmentTreatmentTreatmentTreatment::::
Combined drug therapy for Long time: 2222 totototo 3333 first line drugs for at least 6666----9999 monthsmonthsmonthsmonths.
1111---- First line drugs areFirst line drugs areFirst line drugs areFirst line drugs are::::
DoseDoseDoseDose RouteRouteRouteRoute Side effectSide effectSide effectSide effect
• IsoniazidIsoniazidIsoniazidIsoniazid 10-20 mg/kg/day orally Hepatotoxicity
• RifampicinRifampicinRifampicinRifampicin 10-20 mg/kg/day orally Hepatotoxicity
• PyrazinamidePyrazinamidePyrazinamidePyrazinamide 20202020----40404040 mg/kg/day orally Hepatotoxicity
2222---- Second line drugs are:Second line drugs are:Second line drugs are:Second line drugs are:
DoseDoseDoseDose RouteRouteRouteRoute Side effectSide effectSide effectSide effect
• EthambutolEthambutolEthambutolEthambutol 10-20 mg/kg/day orally
• EthionamideEthionamideEthionamideEthionamide 10-20 mg/kg/day orally
• StreptomycinStreptomycinStreptomycinStreptomycin 20202020----40404040 mg/kg/day IMIMIMIM Ototoxicity, NephrotoxicityOtotoxicity, NephrotoxicityOtotoxicity, NephrotoxicityOtotoxicity, Nephrotoxicity
• KanamycinKanamycinKanamycinKanamycin
BronchialBronchialBronchialBronchial asthmaasthmaasthmaasthma
TTT of acute attack:TTT of acute attack:TTT of acute attack:TTT of acute attack:AAAA----Acute mild to moderate attackAcute mild to moderate attackAcute mild to moderate attackAcute mild to moderate attack::::
1111----BronchodilatorsBronchodilatorsBronchodilatorsBronchodilators:
DoseDoseDoseDose RouteRouteRouteRoute ActionActionActionAction
• BBBB----agonist:agonist:agonist:agonist:
Salbutamol,Salbutamol,Salbutamol,Salbutamol,
Terbutaline,Terbutaline,Terbutaline,Terbutaline,
FenoterolFenoterolFenoterolFenoterol
0.1-0.2 mg/kg/d - Orally in mild attack
- Nebulizer for infants and
young children
- Inhalers for older children
Selective B
agonist
• TheophyllineTheophyllineTheophyllineTheophylline
(methylxanthine(methylxanthine(methylxanthine(methylxanthine
derivatives)derivatives)derivatives)derivatives)
15-20 mg/kg/d orally or rectally direct
relaxation of
bronchialSm.Ms
• Anticholinergic:Anticholinergic:Anticholinergic:Anticholinergic:
IpratropiumIpratropiumIpratropiumIpratropium
250 microgram/dose,
4times daily
Inhalation Reduce the
intrinsic vagal
tone
2222----CorticosteriodsCorticosteriodsCorticosteriodsCorticosteriods:
In moderate or severe cases orally or parenterally orally or parenterally orally or parenterally orally or parenterally (anti-inflammatory and interfere with
synthesis of LKs& PGs)
N.B:N.B:N.B:N.B: Mild cases>>one or 2 bronchodilators are given, inhaled bronchodilator are the best
Moderate cases>>inhaled bronchodilator and oral corticosteroids can be used
5/16/2018 Drugs in Pediatrics - slidepdf.com
http://slidepdf.com/reader/full/drugs-in-pediatrics 2/18
Drugs in Pediatrics NMT11
www.MedadTeam.org 2
BBBB----Acute severe attack (status asthmatics)Acute severe attack (status asthmatics)Acute severe attack (status asthmatics)Acute severe attack (status asthmatics)::::
-Drugs:
DoseDoseDoseDose RouteRouteRouteRouteIntermittent BIntermittent BIntermittent BIntermittent B2222 agonistagonistagonistagonist
nebulized Salbutamolnebulized Salbutamolnebulized Salbutamolnebulized Salbutamol
0.25-0.5 ml added to 2-3 ml saline every 1-2 h inhalation
theophyllinetheophyllinetheophyllinetheophylline 5 mg/k/6 hr IV slowly
hydrocortisonehydrocortisonehydrocortisonehydrocortisone 5-10mg/kg/6 hr IV
Preventive TTT in between attacksPreventive TTT in between attacksPreventive TTT in between attacksPreventive TTT in between attacks:
AntiAntiAntiAnti----inflammatory drugsinflammatory drugsinflammatory drugsinflammatory drugs: it is indicated in persistant asthma
1111----Corticosteriods:Corticosteriods:Corticosteriods:Corticosteriods:
DoseDoseDoseDose RouteRouteRouteRoutebeclomethazonebeclomethazonebeclomethazonebeclomethazone 200-800 microgram/d (4 doses/d) inhaled
BudesinideBudesinideBudesinideBudesinide 200-800 microgram/d (2 doses)
FluticasoneFluticasoneFluticasoneFluticasone 100-500 microgram/d (2 doses)
PrednisonePrednisonePrednisonePrednisone 2mg/kg/d divided doses for 3-10 days oral
2222----AntileukotrinesAntileukotrinesAntileukotrinesAntileukotrines:
DoseDoseDoseDose RouteRouteRouteRoute
Montelukast (Singulair)Montelukast (Singulair)Montelukast (Singulair)Montelukast (Singulair) 5-10mg (once daily) orally
3333----Mast cell stabilizersMast cell stabilizersMast cell stabilizersMast cell stabilizers:
DoseDoseDoseDose RouteRouteRouteRoute
KetotifenKetotifenKetotifenKetotifen 0.06mg/kg/d orally
Na cromoglycateNa cromoglycateNa cromoglycateNa cromoglycate 5-20mg/dose (3-4 doses/d) inhalation
Cardiology
Rheumatic feverRheumatic feverRheumatic feverRheumatic fever
1111----PreventionPreventionPreventionPrevention: (very imp.)
- Prevention of streptococcal infection e.g. proper ventilation
- Early diagnosis of strept. Pharyngitis , then,
- Adequate TTT by:
Benzathine penicillinBenzathine penicillinBenzathine penicillinBenzathine penicillin 1,200,000 IM single injection
OR
Benzathine penicillinBenzathine penicillinBenzathine penicillinBenzathine penicillin 1,200,000 oral at least 10 d
In Allergic Pt.
- Prevention of rheumatic activity in pts with history if R.F.:
ErythromycineErythromycineErythromycineErythromycine 50mg/kg/d
5/16/2018 Drugs in Pediatrics - slidepdf.com
http://slidepdf.com/reader/full/drugs-in-pediatrics 3/18
Drugs in Pediatrics NMT11
www.MedadTeam.org 3
Benzathine penicillinBenzathine penicillinBenzathine penicillinBenzathine penicillin 1,200,000 IM every 2-3 weeks for life
2222----Supportive TTTSupportive TTTSupportive TTTSupportive TTT:- Rest: pts with carditis should have absolute bed rest for at least 4 weeks,
Daily examination is important to detect carditis that usually present within 2w of onset
3333----Specific TTTSpecific TTTSpecific TTTSpecific TTT:
AAAA----Arthritis onlyArthritis onlyArthritis onlyArthritis only (or carditis without cardiomgaly):
SalicylatesSalicylatesSalicylatesSalicylates 100mg/kg for 2w then 74mg/kg for 4-6 w
BBBB----Carditis with cardiomegaly or failureCarditis with cardiomegaly or failureCarditis with cardiomegaly or failureCarditis with cardiomegaly or failure:
PrednisonePrednisonePrednisonePrednisone 2mg/kg/d for 2-3w then taper
SalicylatesSalicylatesSalicylatesSalicylates 75mg/kg/d during tapering 1m after stopping Prednisone
CCCC----ChoreaChoreaChoreaChorea:
PhenobarbitonePhenobarbitonePhenobarbitonePhenobarbitone 3-5 mg/kg/d
HaloperidolHaloperidolHaloperidolHaloperidol 0.02-0.1 mg/kg/d (in pts over 12 years)
4444----TTT of complicationsTTT of complicationsTTT of complicationsTTT of complications: H.F
- Mild cases: complete bed rest, o2, fluid restrictions and steroids
- Sever cases:
DoseDoseDoseDose ActionActionActionAction
furosemidefurosemidefurosemidefurosemide 2mg/kg/d Preload reducing agents(diuretics)
digoxindigoxindigoxindigoxin Digitalizing dose : 0.02-0.05 mg/kg Inotropes
maintenance dose: 0.01 mg/kg/d
captoprilcaptoprilcaptoprilcaptopril may be given After load reducing agents
Infective endocarditisInfective endocarditisInfective endocarditisInfective endocarditis
PreventionPreventionPreventionPrevention
• Dental procedures and surgery:
DoseDoseDoseDose RouteRouteRouteRoute TimingTimingTimingTimingAmoxicillinAmoxicillinAmoxicillinAmoxicillin 50mg/kg (single large dose) oral 1 h. before the procedure
SpecificSpecificSpecificSpecific: immediate parenteral antibiotic for 6 weeks
DoseDoseDoseDose RouteRouteRouteRoute DurationDurationDurationDuration
Penicillin GPenicillin GPenicillin GPenicillin G 300000 IU/kg/day
parenteral for 6 weeksOxacillinOxacillinOxacillinOxacillin 200mg/kg/day
GentamicinGentamicinGentamicinGentamicin 2 mg/kg/day
This treatment is modified according to the results of blood culture
5/16/2018 Drugs in Pediatrics - slidepdf.com
http://slidepdf.com/reader/full/drugs-in-pediatrics 4/18
Drugs in Pediatrics NMT11
www.MedadTeam.org 4
Hepatology
Chronic hepatitisChronic hepatitisChronic hepatitisChronic hepatitis• Antiviral drugsAntiviral drugsAntiviral drugsAntiviral drugs in chronic HBV, HCV have limited response (25%)
• Immunosuppressive (e.g. corticosteroidsImmunosuppressive (e.g. corticosteroidsImmunosuppressive (e.g. corticosteroidsImmunosuppressive (e.g. corticosteroids----azathioprineazathioprineazathioprineazathioprine) in autoimmune hepatitis
• DDDD----penicillamine (copper chelating agent) in Wilson disease.penicillamine (copper chelating agent) in Wilson disease.penicillamine (copper chelating agent) in Wilson disease.penicillamine (copper chelating agent) in Wilson disease. It is the only curable chronic
liver disease and it should be excluded in every case of chronic hepatitis
• Liver implantationLiver implantationLiver implantationLiver implantation in end stage liver disease
CholestasisCholestasisCholestasisCholestasis1111---- Treatment of correctable conditionsTreatment of correctable conditionsTreatment of correctable conditionsTreatment of correctable conditions
• Antibiotics for septicemia.
• Elimination of lactose from diet in galactosemia• Surgical treatment of Choledochal cyst
2222---- Extrahepatic biliary atresiaExtrahepatic biliary atresiaExtrahepatic biliary atresiaExtrahepatic biliary atresia
• Correctable lesion (rare): direct drainage.
• No correctable lesion: kasia (hepatoportoenterostomy).it should be done before 60 daysto obtain best results.
• Liver transplantation for end stage liver disease ( biliary atresia is the commonest
indication )
3333---- SupSupSupSupportive treatmentportive treatmentportive treatmentportive treatment
Nutritional supportNutritional supportNutritional supportNutritional support
• Fat soluble vitamins defeciency is replaced by synthetic water soluble preparations(e.g. for vit A and K) active vit D and vit E is given by injection .
• Medium chain triglycerides containing formulas.
• Calcium, zinc and Phosphorus.
PruritusPruritusPruritusPruritus
• Phenobarbitone
• Cholestramine ( bile acid binder )
Portal hypertensionPortal hypertensionPortal hypertensionPortal hypertension1111---- Management of variceal hemorrhageManagement of variceal hemorrhageManagement of variceal hemorrhageManagement of variceal hemorrhage::::
Emergency therapy for bleeding varicesEmergency therapy for bleeding varicesEmergency therapy for bleeding varicesEmergency therapy for bleeding varices::::
. Anti shock measures: blood transfusion, intravenous fluids.. Correction of coagulopathy: vitamin k, fresh plasma, platelets transfusion
. Nasogastric tube placement
. Vasopressin infusion if bleeding persist
Emergency endoscopyEmergency endoscopyEmergency endoscopyEmergency endoscopy and either injection sclerotherapy or band ligation
Emergency shuntEmergency shuntEmergency shuntEmergency shunt:::: protosystemic shunt
2222---- Prevention of bleeding from varicesPrevention of bleeding from varicesPrevention of bleeding from varicesPrevention of bleeding from varices::::
Prevention of the first attack of bleedingPrevention of the first attack of bleedingPrevention of the first attack of bleedingPrevention of the first attack of bleeding
. Avoid aspirin and non steroid anti inflammatory drugs
. B adrenergic blockers (propranolol) to lower the pressure in portal area
. Prophylactic sclerotherapy or band ligation
5/16/2018 Drugs in Pediatrics - slidepdf.com
http://slidepdf.com/reader/full/drugs-in-pediatrics 5/18
Drugs in Pediatrics NMT11
www.MedadTeam.org 5
prevention of reprevention of reprevention of reprevention of re---- bleedingbleedingbleedingbleeding: in addition to above measures, the following may needed:: in addition to above measures, the following may needed:: in addition to above measures, the following may needed:: in addition to above measures, the following may needed:
.
Surgical protosystemic shunt. .Liver transplantation.
Nephrology
Minimal change nephrotic syndromeMinimal change nephrotic syndromeMinimal change nephrotic syndromeMinimal change nephrotic syndrome Home managementHome managementHome managementHome management:::: for most cases
HospitalizationHospitalizationHospitalizationHospitalization:::: indicated for the first attack or relapses with marked edema
1111---- Supportive treatmentSupportive treatmentSupportive treatmentSupportive treatment::::
.... DietDietDietDiet:::: rich in protein to compensate for protein loss & salt free
Fluid restriction is indicated only in moderate or severe cases of edema
.... Bed restBed restBed restBed rest:::: is not indicated & children with mild edema can attend school
2222---- Specific treatmentSpecific treatmentSpecific treatmentSpecific treatment::::
Control of edemaControl of edemaControl of edemaControl of edema::::
> Mild edema:> Mild edema:> Mild edema:> Mild edema: salt free diet is sufficient
> Moderate edema:> Moderate edema:> Moderate edema:> Moderate edema: diuretics (Furosemide) 1-2 mg/kg/day
FurosemideFurosemideFurosemideFurosemide 1-2222 mg/kg/day diuretics
> Marked edema:> Marked edema:> Marked edema:> Marked edema: intravenous salt free albumin followed by Furosemide
SteroidsSteroidsSteroidsSteroids::::
Induction or remissionInduction or remissionInduction or remissionInduction or remission: Daily therapy: Daily therapy: Daily therapy: Daily therapy
PrednisonePrednisonePrednisonePrednisone 2222 mg/kg/day (60 mg/m2 /day) divided into 3-4 doses
Respose: urine becomes free of albumin usually occurs after 2 weeks. Therapy is continued
for 1 week after that No respose after 1 month: Steroid resistant (renal biopsy is indicated)
MinimalMinimalMinimalMinimal lesionlesionlesionlesion typetypetypetype usuallyusuallyusuallyusually givesgivesgivesgives excellentexcellentexcellentexcellent resposeresposeresposerespose totototo corticosteroidscorticosteroidscorticosteroidscorticosteroids
Maintenance of remissionMaintenance of remissionMaintenance of remissionMaintenance of remission: Alternate day therapy: Alternate day therapy: Alternate day therapy: Alternate day therapy
For thoseFor thoseFor thoseFor those who responded to prednisonewho responded to prednisonewho responded to prednisonewho responded to prednisone
PrednisonePrednisonePrednisonePrednisone 2222 mg/kg/day single morning dose after breakfast every other day for 3-6 ms
RelapsesRelapsesRelapsesRelapses:::: Relapse is the recurrence of edema. It is treated as the initial attack but
alternate day therapy is continued for longer period ( (( (6 66 6- -- -12 12 12 12 months) months) months) months)
CyclophosphamideCyclophosphamideCyclophosphamideCyclophosphamide 2222-3 mg/kg/day single dose for 8 weeks
- in steroid resistant and in cases with frequent relapses
- alternate day therapy with low prednisone is continued during therapy- Total leucocytic count is monitored every week (stop therapy if count drops below
3000/mm3
3333---- Treatment of complications: treatment of infectionsTreatment of complications: treatment of infectionsTreatment of complications: treatment of infectionsTreatment of complications: treatment of infections
. Antibiotics:. Antibiotics:. Antibiotics:. Antibiotics: Penicillin Penicillin Penicillin Penicillin for urgent treatment of any suspected infections (peritonitis & skin
infections)
Acute poststreptococcal glomerulonephritisAcute poststreptococcal glomerulonephritisAcute poststreptococcal glomerulonephritisAcute poststreptococcal glomerulonephritis Home managementHome managementHome managementHome management:::: for most cases. More than 95 5 of cases will recover completely within
few weeks & even without therapy
5/16/2018 Drugs in Pediatrics - slidepdf.com
http://slidepdf.com/reader/full/drugs-in-pediatrics 6/18
Drugs in Pediatrics NMT11
www.MedadTeam.org 6
HospitalizationHospitalizationHospitalizationHospitalization:::: for cases complicated with severe hypertension, marked congestion or severe
renal failure
Supporative treatment:Supporative treatment:Supporative treatment:Supporative treatment:
- RestRestRestRest: indicated only during the oliguria phase of illness (first week)
- DietDietDietDiet:
High carbohydrate diet High carbohydrate diet High carbohydrate diet High carbohydrate diet
Salt & protein restriction Salt & protein restriction Salt & protein restriction Salt & protein restriction during the oliguria phase and in the presence of
complications e.g: hypertension & marked congestion
Fluid balance: Fluid balance: Fluid balance: Fluid balance: amount of fluids/day = urine output of the previous day + insensible
water loss (400cc/m2)
Specific treatment:Specific treatment:Specific treatment:Specific treatment:
- Control of edemaControl of edemaControl of edemaControl of edema:
. In most cases edema subsides spontaneously by the end of the first week. Fluid
restriction & salt restriction during the first week are usually sufficient. Diuretics e.g: Frusemide Frusemide Frusemide Frusemide , in some cases
- Control of hypertensionControl of hypertensionControl of hypertensionControl of hypertension (when diastolic pressure exceeds 95 mmHg- usually one oral
antihypertensive drugs is sufficient)
CaptoprilCaptoprilCaptoprilCaptopril 0.5-1 mg/kg/day divided into 3-4 doses) ACE Inhibitor
B blockersB blockersB blockersB blockers
- For eradication of any streptococcal infection
PenicillinPenicillinPenicillinPenicillin oral 10 days course
Treatment of complications:Treatment of complications:Treatment of complications:Treatment of complications:
Renal failureRenal failureRenal failureRenal failure diuretics, fluid restriction, treatment of acidosis, dialysis)
Heart failureHeart failureHeart failureHeart failure Dopamine not digitalisHypertensiveHypertensiveHypertensiveHypertensive
encephalopathyencephalopathyencephalopathyencephalopathy
I.V. Diazoxide
Chronic renal failureChronic renal failureChronic renal failureChronic renal failure Periodic clinical evaluationPeriodic clinical evaluationPeriodic clinical evaluationPeriodic clinical evaluation: nutritional status, growth, blood pressure, cariac function &
skeletal examination for rachitic changes
Laboratory evaluationLaboratory evaluationLaboratory evaluationLaboratory evaluation: blood urea, creatinine, acid base status-serum electrolytes (Na,K,Ca,P)
hemoglobin level & radiological examination of bones for evidence of rachitic changes
Measurement of glomerular filtration rateMeasurement of glomerular filtration rateMeasurement of glomerular filtration rateMeasurement of glomerular filtration rate: is important to determine the degree of renal
insufficiency:. Values between 20-30 ml/min/m2: manifestations of renal failure appear
. Values below 10 ml/min/m2 denote severe renal insufficiency
1- Conservative measuresConservative measuresConservative measuresConservative measures: mild to moderate cases of renal insufficieny with GFR above 10
ml/min/m2
- DietDietDietDiet:
. Carbohydrate & fat: Carbohydrate & fat: Carbohydrate & fat: Carbohydrate & fat: allowed freely to provide sufficient calories
.
Protein restriction Protein restriction Protein restriction Protein restriction to dercearse the nitrogenous waste products
. Salt restriction Salt restriction Salt restriction Salt restriction in cases with hypertension
- DrugsDrugsDrugsDrugs:
5/16/2018 Drugs in Pediatrics - slidepdf.com
http://slidepdf.com/reader/full/drugs-in-pediatrics 7/18
Drugs in Pediatrics NMT11
www.MedadTeam.org 7
RicketsRicketsRicketsRickets active form of Vitamin D
Growth failureGrowth failureGrowth failureGrowth failure feeding regimen-growth hormone therapy
HHHHypertensionypertensionypertensionypertension salt restriction, oral furosemide & anti-hypertensive drugsHHHHyperphsphatemia &yperphsphatemia &yperphsphatemia &yperphsphatemia &
hhhhypocalcemiaypocalcemiaypocalcemiaypocalcemia
> Oral calcium supplementation
> Vit D therapy
> Oral aluminium hydroxide
AAAAnaemianaemianaemianaemia erythropoietin & packed RBCs
AAAAcidosiscidosiscidosiscidosis oral NaHco3
AAAAntibioticsntibioticsntibioticsntibiotics for severe urinary tract infection or severe systemic infections as it
may precipitate an episode of acute renal failure
2- DialysisDialysisDialysisDialysis: severe renal insufficiency with GFR below 10 ml/min/m2 or when conservation
measures are no longer effective
- Peritoneal (continous ambulatory or chronic cycling)- Hemodialysis
3- Renal transplantationRenal transplantationRenal transplantationRenal transplantation:
- It is the ideal therapy for children with severe renal insufficiency
- It can be carried out in children above the age of 5 years
- Problems limiting its application include: graft rejection, finding suitable donor
Urinary tract infectionUrinary tract infectionUrinary tract infectionUrinary tract infectionProper antibiotics according to culture and sensitivity
1111.... Acute casesAcute casesAcute casesAcute cases:
PyelonephritisPyelonephritisPyelonephritisPyelonephritis:
DrugsDrugsDrugsDrugs DoseDoseDoseDose RouteRouteRouteRoute
GentamicxinGentamicxinGentamicxinGentamicxin
ampicillinampicillinampicillinampicillin
4 mg/kg/day
100 mg/kg/day
IV initially then shift to oral therapy
after 5 days if the patient is improving
Duration of therapy 10-14 days
Urine should be sterile within 48 hours of adequate therapy
CystitisCystitisCystitisCystitis:
DrugsDrugsDrugsDrugs DoseDoseDoseDose RouteRouteRouteRoute
Amoxicillin or coAmoxicillin or coAmoxicillin or coAmoxicillin or co----trimoxazoltrimoxazoltrimoxazoltrimoxazol 50 mg/kg/day oral
For 7-10 days
Treatment can be adjusted according to the results of urine culture and sensitivity
2222.... Recurrent casesRecurrent casesRecurrent casesRecurrent cases: After eradication of infection the following should be done:
- Suppressive therapy with co-trimoxazol (Trimethoprim-sulfamethoxazole) given in lower
dose (one third of usual therapeutic dose)
- Adequate fluid intake
- Frequent voiding
- Avoid constipation
Nocturnal enuresisNocturnal enuresisNocturnal enuresisNocturnal enuresis- Identification & treatment of organic causesorganic causesorganic causesorganic causes e.g. urinary tract infection & polyuria
Simple measures in children aboveSimple measures in children aboveSimple measures in children aboveSimple measures in children above 4444 yearsyearsyearsyears:
5/16/2018 Drugs in Pediatrics - slidepdf.com
http://slidepdf.com/reader/full/drugs-in-pediatrics 8/18
Drugs in Pediatrics NMT11
www.MedadTeam.org 8
- Fluid restriction after dinner
- Let the child urinate before sleep
- Wake the child up by night to urinate- Rewarding for dry night
- Punishment should be avoided
Drug therapy in children aboveDrug therapy in children aboveDrug therapy in children aboveDrug therapy in children above 6666 yearsyearsyearsyears:
OxybutyrinOxybutyrinOxybutyrinOxybutyrin Anticholinergic drugs increase bladder capacity
DesmopressinDesmopressinDesmopressinDesmopressin vasopressin analog single night dose 0.1-0.2 mg
Alarm deviceAlarm deviceAlarm deviceAlarm device it gives a ring immediately at the beginning of wetting so the child can wake up
for urination
Neurology
EpilepsyEpilepsyEpilepsyEpilepsyI- Treatment of the ongoing seizures or treatment of status epilepticusTreatment of the ongoing seizures or treatment of status epilepticusTreatment of the ongoing seizures or treatment of status epilepticusTreatment of the ongoing seizures or treatment of status epilepticus.
• First aid measuresFirst aid measuresFirst aid measuresFirst aid measures
- Patent airway - O2 - IV line
• Immediate anticonvulsant drugsImmediate anticonvulsant drugsImmediate anticonvulsant drugsImmediate anticonvulsant drugs
DiazepamDiazepamDiazepamDiazepam 0.3-0.5 mg/kg IV or rectal
PhenobarbitonePhenobarbitonePhenobarbitonePhenobarbitone 10-15 mg/kg (loading dose) that can be repeated
5 mg/kg (maintenance dose) after seizure control
If phenobarbitone failed to control the seizures shift to other drugs
PhenytoinPhenytoinPhenytoinPhenytoin 15-20 mg/kg (loading dose)
5 mg/kg/day (maintenance)
Na valproateNa valproateNa valproateNa valproate 20-40 mg rectally
IIIIIIII---- Prevention of recurrence by antiepileptic drugsPrevention of recurrence by antiepileptic drugsPrevention of recurrence by antiepileptic drugsPrevention of recurrence by antiepileptic drugs
- DrugsDrugsDrugsDrugs:
DrugDrugDrugDrug Seizure typeSeizure typeSeizure typeSeizure type
Dose(mg/kg/day)Dose(mg/kg/day)Dose(mg/kg/day)Dose(mg/kg/day)
1111---- Sodium valproateSodium valproateSodium valproateSodium valproate
- Generalized seizures:
Tonic clonic, Absence and myoclonic
- Partial seizures
10-40
2222---- CarbamazepineCarbamazepineCarbamazepineCarbamazepine - Partial seizures: the best in partial seizures- Generalized tonic clonic
10-30
3333---- PhenobarbitonePhenobarbitonePhenobarbitonePhenobarbitone- Generalized tonic clonic
- Partial seizures3-5
4444---- PhenytoinPhenytoinPhenytoinPhenytoin As phenobarbitone 5-8
5555---- ClonazepamClonazepamClonazepamClonazepam- Myoclonic
- Infantile spasms0.05-0.1
6666---- EthosuximideEthosuximideEthosuximideEthosuximide- absence
- Myoclonic20-40
5/16/2018 Drugs in Pediatrics - slidepdf.com
http://slidepdf.com/reader/full/drugs-in-pediatrics 9/18
Drugs in Pediatrics NMT11
www.MedadTeam.org 9
7777---- Vigabatrin Vigabatrin Vigabatrin Vigabatrin- Partial
- Infantile spasms
40-80
8888---- LamotrigineLamotrigineLamotrigineLamotrigine - Atypical absence seizures 5-109999---- TopiramateTopiramateTopiramateTopiramate - Partial seizures 5-10
10101010---- CorticosterioidsCorticosterioidsCorticosterioidsCorticosterioids
and ACTHand ACTHand ACTHand ACTH
- Infantile spasms, myoclonic seizures
- Symptomatic intractable seizures
- IIIImportantmportantmportantmportant rulesrulesrulesrules for long term drug therapyfor long term drug therapyfor long term drug therapyfor long term drug therapy
1- Initiation of therapy only after accurate diagnosis.
2- Choice of drugs according to clinical and EEG findings.
3- Number of drugs: start with one drug in small dose (to avoid toxicity and improve
compliance) then increases gradually until seizure control or maximum dose is reached
. Failure of the first drug is an indication to add the second drug.
4- Duration and termination of therapy
At least 2 years after the child is being seizure free – termination should be gradually.
5- Patent counseling
Avoid watching TV except in lighted room and far enough from the screen.
Computer games should be done under supervision
MeningitisMeningitisMeningitisMeningitis1111---- PreventionPreventionPreventionPrevention
---- Vaccination Vaccination Vaccination Vaccination
· Infants in the first year of life:- HIB vaccine HIB vaccine HIB vaccine HIB vaccine 3 33 3 doses doses doses doses (against Hemophilus influenza)
· Children:- Meningococcal polysaccharide vaccine (A and C) at Meningococcal polysaccharide vaccine (A and C) at Meningococcal polysaccharide vaccine (A and C) at Meningococcal polysaccharide vaccine (A and C) at 3 33 3 years years years years
---- ChemoprophylaxisChemoprophylaxisChemoprophylaxisChemoprophylaxis· Rifampicin Rifampicin Rifampicin Rifampicin used to eradicate meningococci from the nasopharynx of carriers and
minimize the risk of contact infection.
2222---- Supportive treatmentSupportive treatmentSupportive treatmentSupportive treatment
- -- - I.V fluid I.V fluid I.V fluid I.V fluid if meningitis is complicated by shock (otherwise it should be restricted to minimize
cerebral edema)
- Blood transfusion for cases with DIC
- Anticonvulsants: diazepam and phenoparbitone diazepam and phenoparbitone diazepam and phenoparbitone diazepam and phenoparbitone
3333---- Specific treatment: antibioticsSpecific treatment: antibioticsSpecific treatment: antibioticsSpecific treatment: antibiotics
Neonates 3 weeks Initial antibiotics should be active against
haemophilus influenzae type b, streptococci haemophilus influenzae type b, streptococci haemophilus influenzae type b, streptococci haemophilus influenzae type b, streptococci
and menin and menin and menin and meningococci gococci gococci gococci , then modified according
to the result of culture and sensitivity tests
IV IV IV IV for at least
10 10 10 10- -- - 14 14 14 14 days days days days
Neonates and infants younger
than 2 months
Cefotriaxone Cefotriaxone Cefotriaxone Cefotriaxone 100 100 100 100 mg kg/day mg kg/day mg kg/day mg kg/day ,
ChloramphenicolChloramphenicolChloramphenicolChloramphenicol 100 100 100 100 mg kg/day mg kg/day mg kg/day mg kg/day ,
Ampicillin Ampicillin Ampicillin Ampicillin 100 100 100 100 mg kg/day mg kg/day mg kg/day mg kg/day ,
Infants and children older than
2 months
Third generation cephalosporin and cephalosporin and cephalosporin and cephalosporin and
chloramphenicol chloramphenicol chloramphenicol chloramphenicol
N.B Corticosteroids for H influenza improve CSF findings and decrease the incidence of
hearing loss
5/16/2018 Drugs in Pediatrics - slidepdf.com
http://slidepdf.com/reader/full/drugs-in-pediatrics 10/18
Drugs in Pediatrics NMT11
www.MedadTeam.org 10
4444---- Treatment of complicationsTreatment of complicationsTreatment of complicationsTreatment of complications
· Assisted ventilation if respiratory failure occurs.
· Subdural taps to evacuate extensive subdural effusions5555---- Follow up after treatmentFollow up after treatmentFollow up after treatmentFollow up after treatment
.Children who have meningitis should have a complete neurological evaluation at the time of
discharge (vision, hearing and developmental assessment).
. Periodic follow up for at least 2 years is recommended.
Nutritional disorders
Protein energy malnutritionProtein energy malnutritionProtein energy malnutritionProtein energy malnutrition
Prevention of protein energy malnutritionPrevention of protein energy malnutritionPrevention of protein energy malnutritionPrevention of protein energy malnutrition
1111---- Breast feeding Breast feeding Breast feeding Breast feeding promotion (it is the most important)
Enumerate factors important for successful breast feeding
2222---- Health education Health education Health education Health education of the mother about infant feeding
3333---- Assessment of nutritional status Assessment of nutritional status Assessment of nutritional status Assessment of nutritional status during infancy in every visit for earlier diagnosis of nutritional
deficiency disorders
Management of protein energy malnutritionManagement of protein energy malnutritionManagement of protein energy malnutritionManagement of protein energy malnutrition
1111----Hospital managementHospital managementHospital managementHospital management
• Indication
. 3rd
degree marasmus. Kwashiorkor or marasmic kwashiorkor (edema)
. Infections e.g. pneumonia, diarrhea
• Treatment of life threatening conditions is the initial line of management:-
. Control of infections Control of infections Control of infections Control of infections by proper antibiotics according to culture & sensitivity
. Correction of shock, dehydration & electrolyte imbalance Correction of shock, dehydration & electrolyte imbalance Correction of shock, dehydration & electrolyte imbalance Correction of shock, dehydration & electrolyte imbalance by proper I.V. fluids
. Correction of anemia Correction of anemia Correction of anemia Correction of anemia by blood or packed red cells 10-15cc/kg
. Prevention of hypothermia Prevention of hypothermia Prevention of hypothermia Prevention of hypothermia (adequate clothing & external heat)
2222----Home or hospital: nutritionalHome or hospital: nutritionalHome or hospital: nutritionalHome or hospital: nutritional management:management:management:management:
MarasmusMarasmusMarasmusMarasmus KwashiorkorKwashiorkorKwashiorkorKwashiorkor
TypeTypeTypeType . Milk Milk Milk Milk : in young non-weaned
infants
. Other foodOther foodOther foodOther food (balanced diet): in
older weaned infants
. Milk Milk Milk Milk : start with soy based lactose free
formula (lactose intolerance), then gradually
shift to standard formulas
. Other food Other food Other food Other food :
Animal protein (high biological value):
eggs, chicken, meat & yogurt
Plant protein: lentils, beans
Fresh vegetables & fruits are added
AmountAmountAmountAmount . 150-200 Kcal. / kg / day . High protein diet: 4-6 gram protein/kg/day
5/16/2018 Drugs in Pediatrics - slidepdf.com
http://slidepdf.com/reader/full/drugs-in-pediatrics 11/18
Drugs in Pediatrics NMT11
www.MedadTeam.org 11
N.B:N.B:N.B:N.B:
calculation according to actual
body weight & gradually increase(5-10 Kcal/kg/day) every day or
every other day according to the
infant tolerance
RouteRouteRouteRoute Orally Orally Orally Orally . Nasogastric tube Nasogastric tube Nasogastric tube Nasogastric tube may be required if there
is marked anorexia
. Parentral feeding Parentral feeding Parentral feeding Parentral feeding may be required in
severe cases
N.BN.BN.BN.B: Kwashiorkor Kwashiorkor Kwashiorkor Kwashiorkor (more difficult to manage because of anorexia)
Marasmus & kwashiorkorMarasmus & kwashiorkorMarasmus & kwashiorkorMarasmus & kwashiorkor
- Treatment of vitamin & mineral deficiency
Vit Vit Vit Vit. A. A. A. A Single doseSingle doseSingle doseSingle dose
50 000 IU (age up to 6 months)
100 000 IU (from 6 months to one year)
200 000 IU (more than one year)
Folic acid Folic acid Folic acid Folic acid – –– – iron iron iron iron (4-6 mg/kg/day) in 3 doses
Others Others Others Others vitamin D, C & B complex – minerals as (potassium & zinc)
- Treatment of parasitic infestations if present
RicketsRicketsRicketsRickets
Preventive treatmentPreventive treatmentPreventive treatmentPreventive treatment:
Vitamin D orally Vitamin D orally Vitamin D orally Vitamin D orally daily from
the second month of life
Full termFull termFull termFull term: 400-800 IU
PretermPretermPretermPreterm: 1000-1500 IU from the age of one month
Exposure to sun Exposure to sun Exposure to sun Exposure to sun
Diet rich in vitamin D Diet rich in vitamin D Diet rich in vitamin D Diet rich in vitamin D e.g. egg yolk, liver, oily fish
Specific treatmentSpecific treatmentSpecific treatmentSpecific treatment::::
1111----Vitamin D therapy Vitamin D therapy Vitamin D therapy Vitamin D therapy Vitamin D deficiency rickets is sensitive to vitamin D in ordinary doses
Oral treatmentOral treatmentOral treatmentOral treatment I.M injectionI.M injectionI.M injectionI.M injection
Daily for 2-4 weeks Single injection without further therapy
Vitamin D3 :2000-5000 IU/day
OROROROR
1.25 dihydroxycholecalciferol 0.5-2 Mg/day
600.000 IU
N.B N.B N.B N.B: If nononono healinghealinghealinghealing occurs the rickets is probably resistant to vitamin D resistant to vitamin D resistant to vitamin D resistant to vitamin D
5/16/2018 Drugs in Pediatrics - slidepdf.com
http://slidepdf.com/reader/full/drugs-in-pediatrics 12/18
Drugs in Pediatrics NMT11
www.MedadTeam.org 12
N.B: N.B: N.B: N.B: Injection treatment may be better than oral treatment because of Injection treatment may be better than oral treatment because of Injection treatment may be better than oral treatment because of Injection treatment may be better than oral treatment because of:
More rapid healing
Less dependence on parents for daily administration
Earlier differential diagnosis from vitamin D resistant rickets
2222----Instructions to the parentsInstructions to the parentsInstructions to the parentsInstructions to the parents:
Diet rich in vitamin D Diet rich in vitamin D Diet rich in vitamin D Diet rich in vitamin D
Proper sun exposure Proper sun exposure Proper sun exposure Proper sun exposure
Treatment of complicationsTreatment of complicationsTreatment of complicationsTreatment of complications:
- Tetany Tetany Tetany Tetany: :: : 1ml/kg calcium gluconate 10% I.V slowly to be accompanied by oral calcium
- Treatment of iron deficiency anemia Treatment of iron deficiency anemia Treatment of iron deficiency anemia Treatment of iron deficiency anemia by oral iron therapy 6 mg/kg/day
- Deformities Deformities Deformities Deformities: surgical treatment if sever and persistent
Infections
RashesRashesRashesRashes
MeaslesMeaslesMeaslesMeasles Scarlet feverScarlet feverScarlet feverScarlet fever Chicken boxChicken boxChicken boxChicken box
PreventionPreventionPreventionPrevention • Active : measles measles measles measles
vaccine vaccine vaccine vaccine (MMR)
• Passive: immune immune immune immune serum globulin serum globulin serum globulin serum globulin
(0.25ml/kg IM)
within 5 days after
exposure. The dose
increased if delayed
beyond the 5th day.
Prevention of droplet droplet droplet droplet
infection infection infection infection .• Live attenuated Live attenuated Live attenuated Live attenuated
varicella vaccine varicella vaccine varicella vaccine varicella vaccine is
being used
SupportiveSupportiveSupportiveSupportive
treatmenttreatmenttreatmenttreatment• Diet : increase fluid fluid fluid fluid
intake
• Drugs Drugs Drugs Drugs :
Cough : sedatives
Fever : anti-pyretic Eye : eye drops
• Diet : increase fluid fluid fluid fluid
intake
• Drugs Drugs Drugs Drugs : symptomatic
treatment
Fever : anti-pyretic Headache & pain :
analgesics
• Itching Itching Itching Itching : local &
systemic anti-pruritic
agents
• Fever Fever Fever Fever : antipyretics-not
aspirin-as it increasesthe risk of Reye
syndrome in which
there is acute
encephalopathy and
fatty degeneration of
the viscera
SpecificSpecificSpecificSpecific
treatmenttreatmenttreatmenttreatment• No specific No specific No specific No specific
treatment treatment treatment treatment
• Large doses of
• Penicillin : Penicillin : Penicillin : Penicillin : is the
drug of choice : oral
penicillin V 400.000
• Antiviral drugs
(Acyclovir) (Acyclovir) (Acyclovir) (Acyclovir) in
immunocompromised
5/16/2018 Drugs in Pediatrics - slidepdf.com
http://slidepdf.com/reader/full/drugs-in-pediatrics 13/18
Drugs in Pediatrics NMT11
www.MedadTeam.org 13
gamma globulin gamma globulin gamma globulin gamma globulin in
encephalitis
• Oral vitamin Avitamin Avitamin Avitamin A( 400,000 IU) in
severe cases
• I.V vitamin Avitamin Avitamin Avitamin A for
measles affecting
kwashiorkor
IU/dose 3 times/day
for at least 10 days
• Erythromycin : Erythromycin : Erythromycin : Erythromycin : (40 mg/kg/day)
in penicillin sensitive
patients
patients
Treatment of Treatment of Treatment of Treatment of
complicationscomplicationscomplicationscomplications
Otitis media &
bronchopneumonia
are treated by proper
antibiotics
Re-examination after 2-
3 weeks for detection
and management of
remote complications
e.g. Rheumatic fever &
glomerulonephritis.
Skin infections: by proper
antibiotics
Rest of rashes:Rest of rashes:Rest of rashes:Rest of rashes:
1) RubellaRubellaRubellaRubella : ttt is the same items as in measles
2) Roseola infantumRoseola infantumRoseola infantumRoseola infantum :
• Antipyretics
• Sedatives to infants susceptible to febrile convulsions
3) Infectious mononucleosisInfectious mononucleosisInfectious mononucleosisInfectious mononucleosis : No specific treatment
Rest of infectionsRest of infectionsRest of infectionsRest of infections
MumpsMumpsMumpsMumps TetanusTetanusTetanusTetanus DiphtheriaDiphtheriaDiphtheriaDiphtheria
PreventionPreventionPreventionPrevention • Active : Mumps Mumps Mumps Mumps
vaccine or MMR vaccine or MMR vaccine or MMR vaccine or MMR
• Passive : hyper hyper hyper hyper
immune mumps immune mumps immune mumps immune mumps
gamma gamma gamma gamma globulins globulins globulins globulins (of
value if given early in
the incubation
period)
• DPTDPTDPTDPT
• Tetanus toxoid Tetanus toxoid Tetanus toxoid Tetanus toxoid during
pregnancy for
prevention of tetanus
neonatorum
• Following injury : if not
immunized, human human human human
antitetanus antitetanus antitetanus antitetanus
immunoglobulin immunoglobulin immunoglobulin immunoglobulin 250-
500 units I.M or tetanus tetanus tetanus tetanus
antitoxin antitoxin antitoxin antitoxin 3000 units
DPT vaccine DPT vaccine DPT vaccine DPT vaccine
SupportiveSupportiveSupportiveSupportive
treatmenttreatmenttreatmenttreatment• MMMMeasures to relieveeasures to relieveeasures to relieveeasures to relieve
painpainpainpain:1. Analgesics
2. Parotitis : heat to
the glands
3. Orchitis : ice bags
• Isolation Isolation Isolation Isolation and nursing in
a dark quiet room
• Control of convulsions Control of convulsions Control of convulsions Control of convulsions
(patent airways,
oxygen, diazepam)
• Maintenance of fluids Maintenance of fluids Maintenance of fluids Maintenance of fluids
• Rest Rest Rest Rest : complete bed
rest if myocarditis is
diagnosed
• Proper hydration and Proper hydration and Proper hydration and Proper hydration and
high caloric intake high caloric intake high caloric intake high caloric intake
• Tube feeding Tube feeding Tube feeding Tube feeding for
5/16/2018 Drugs in Pediatrics - slidepdf.com
http://slidepdf.com/reader/full/drugs-in-pediatrics 14/18
Drugs in Pediatrics NMT11
www.MedadTeam.org 14
– support the
testis
• MMMMouthouthouthouth: antisepticsolutions to keep it
clean
and electrolyte balance and electrolyte balance and electrolyte balance and electrolyte balance palatal or pharyngeal
paralysis pt to avoid
aspiration
SpecificSpecificSpecificSpecific
treatmenttreatmenttreatmenttreatment
No specific treatment • Human tetanus Human tetanus Human tetanus Human tetanus
immunoglobulin immunoglobulin immunoglobulin immunoglobulin 5000500050005000----
10000100001000010000 I.M (single dose,
neither allergy nor
anaphylaxis and more
persistent titers)
• Tetanus antitoxin Tetanus antitoxin Tetanus antitoxin Tetanus antitoxin
50005000500050000-100001000010000100000U
(1/2I.M and ½ I.V) aftersensitivity test
• Antibiotics to eradicate Antibiotics to eradicate Antibiotics to eradicate Antibiotics to eradicate
the organism the organism the organism the organism: :: : penicillin
G 10000100001000010000U/Kg/day I.V
for 10days
• Wound: cleaned, left Wound: cleaned, left Wound: cleaned, left Wound: cleaned, left
opened and deprided opened and deprided opened and deprided opened and deprided
1. Antitoxin Antitoxin Antitoxin Antitoxin to
neutralize the
exotoxin 40000-
100000 units I.M or
½ I.M and ½ I.V
after sensitivity test
2. Antibiotic Antibiotic Antibiotic Antibiotic to
eradicate the
organism• Procaine penicillin Procaine penicillin Procaine penicillin Procaine penicillin
600000 I.U for 7-
10 days
• Erythromycin Erythromycin Erythromycin Erythromycin 40
mg/kg/day for 7-
10 days
(forsensitive pt)
Treatment of Treatment of Treatment of Treatment of
complicationscomplicationscomplicationscomplications
Encephalitis : control
of convulsions and
measures to lower theincreased tension
Respiratory support for
cases with asphyxia
TTT of PertussisTTT of PertussisTTT of PertussisTTT of Pertussis :
• Erythromycin Erythromycin Erythromycin Erythromycin: 50505050mg/kg/daymg/kg/daymg/kg/daymg/kg/day for 14 days may abort or eliminate the disease if given early.
GIT
Vomiting & Persistent diarrhea Vomiting & Persistent diarrhea Vomiting & Persistent diarrhea Vomiting & Persistent diarrhea
Vomiting Vomiting Vomiting Vomiting Persistent diarrheaPersistent diarrheaPersistent diarrheaPersistent diarrhea
- Treatment of the cause
- Antiemetic :
Metoclopramide : 0.5mg / kg /day
inininin 3 33 3 divided doses divided doses divided doses divided doses
Dompridone : 1mg / kg /day inininin 3 33 3
divided doses divided doses divided doses divided doses
Removal of the offending agent from diet Removal of the offending agent from diet Removal of the offending agent from diet Removal of the offending agent from diet e.g.
- lactose : give instead lactose free formula
(Isomil)
- Cow’s milk: give instead soy bean based
formula.
Fat Fat Fat Fat given as medium chain triglycerides to
facilitate absorption.
Vitamins Vitamins Vitamins Vitamins especially vitamin vitamin vitamin vitamin AAAA and trace elements
5/16/2018 Drugs in Pediatrics - slidepdf.com
http://slidepdf.com/reader/full/drugs-in-pediatrics 15/18
Drugs in Pediatrics NMT11
www.MedadTeam.org 15
GastroenteritisGastroenteritisGastroenteritisGastroenteritis
1111---- Home management : mild to moderate casesHome management : mild to moderate casesHome management : mild to moderate casesHome management : mild to moderate cases• Rehydration solutionsRehydration solutionsRehydration solutionsRehydration solutions: most imp. Item in management.
o Principle: Glucose- facilitated Na absorption mechanism.
o Composition:
NaCl:NaCl:NaCl:NaCl: 3.53.53.53.5 gmgmgmgm
To beTo beTo beTo be
dissolveddissolveddissolveddissolved
in onein onein onein one
literliterliterliter
Na:Na:Na:Na: 90909090mEq/LmEq/LmEq/LmEq/L
NaHCONaHCONaHCONaHCO3333:::: 2.52.52.52.5gmgmgmgm Cl :Cl :Cl :Cl : 80808080mEq/LmEq/LmEq/LmEq/L
KCl :KCl :KCl :KCl : 1.51.51.51.5 gmgmgmgm K:K:K:K: 20202020mEq/LmEq/LmEq/LmEq/L
Glucose :Glucose :Glucose :Glucose : 20202020 gmgmgmgm Glucose:Glucose:Glucose:Glucose:111111111111mmol/Lmmol/Lmmol/Lmmol/L
o Indications
All cases with mild and moderate dehydration
o Dose 50-100 ml/kg according to the degree of dehydration to be given over 4-6 hours.
Thirst mechanism is effective in regulating the amount giving to the child.
o Method
Usually given by spoon or cup.spoon or cup.spoon or cup.spoon or cup.
Nasogastric tube Nasogastric tube Nasogastric tube Nasogastric tube may be used in case of:
a- Refusal of ORS
b- Newborn in an incubator
c- Uncooperative mother
o Advantages:
Suitable for all age groups all age groups all age groups all age groups All types of All types of All types of All types of diarrhea diarrhea diarrhea diarrhea
All types of All types of All types of All types of dehydration dehydration dehydration dehydration provided that Na level is between 115-165 mEq/L
• FeedingFeedingFeedingFeeding:
Should not be delayed Should not be delayed Should not be delayed Should not be delayed Delay repair of intestinal cells Persistant diarrhea
Shortly after starting rehydration therapy
o In breast fed infants: breast breast breast breast milk milk milk milk is given in small amounts and gradually increased
according to child's tolerance.
o In formula fed infants: start with diluted formula diluted formula diluted formula diluted formula (1/4 strength) and increase the
conc. gradually.
o In older children: gradual introduction of solid food solid food solid food solid food beginning with vegetables
fruits and jellies.• Treatment of infectionTreatment of infectionTreatment of infectionTreatment of infection: Self Self Self Self- -- -limited limited limited limited
Antibiotics may kill normal flora Antibiotics may kill normal flora Antibiotics may kill normal flora Antibiotics may kill normal flora persistant diarrhea
o Antibiotics are indicated in:
a- Cholera
b- Giardia, entameba,: Metronidazole 25252525mg/kg/daymg/kg/daymg/kg/daymg/kg/day( Giardia) and 50505050mg/kg/daymg/kg/daymg/kg/daymg/kg/day
(Entameba)
c- Shigella
• Symptomatic treatmentSymptomatic treatmentSymptomatic treatmentSymptomatic treatment
5/16/2018 Drugs in Pediatrics - slidepdf.com
http://slidepdf.com/reader/full/drugs-in-pediatrics 16/18
Drugs in Pediatrics NMT11
www.MedadTeam.org 16
2222---- Hospital management for severe complicated casesHospital management for severe complicated casesHospital management for severe complicated casesHospital management for severe complicated cases
• IndicationsIndicationsIndicationsIndications
o Deterioration Deterioration Deterioration Deterioration of the patient during home management
o Severe dehydration dehydration dehydration dehydration or shock
o Severe vomiting vomiting vomiting vomiting
o The presence of serious complications complications complications complications : septicemia, metabolic acidosis or bleeding.
AAAA---- Intravenous rehydrationIntravenous rehydrationIntravenous rehydrationIntravenous rehydration
Shock therapyShock therapyShock therapyShock therapy Deficit therapyDeficit therapyDeficit therapyDeficit therapy Maintenance therapyMaintenance therapyMaintenance therapyMaintenance therapy
( over 1111 hour) (over 8888 hrs) ( over 24242424 hrs)
Lactated ringer Lactated ringer Lactated ringer Lactated ringer
sol.sol.sol.sol. ((((20202020 ml/ ml/ ml/ ml/kg)kg)kg)kg)
Glucose Glucose Glucose Glucose 5% 5% 5% 5% and saline in ratio and saline in ratio and saline in ratio and saline in ratio 1:1 1:1 1:1 1:1
aaaa---- 40404040ml/kg in mildmildmildmild dehydration
bbbb---- 80808080ml/kg in moderatemoderatemoderatemoderate cases
cccc---- 120120120120ml/kg in severesevereseveresevere dehydration
Glucose Glucose Glucose Glucose 5% 5% 5% 5% and saline in a ratio and saline in a ratio and saline in a ratio and saline in a ratio 4:1 4:1 4:1 4:1
aaaa---- 100100100100ml/kg for the firstfirstfirstfirst 10101010 kgkgkgkg
bbbb---- 50505050ml/kg for each kg fromfromfromfrom 11111111----20202020 kgkgkgkg
cccc---- 20202020ml/kg for each kg aboveaboveaboveabove 20202020 kgkgkgkg
Deficit therapyDeficit therapyDeficit therapyDeficit therapy in hypernatremic dehydration is made with only 70% of the
calculated amount and should be given slowly to prevent brain edema.
PotassiumPotassiumPotassiumPotassium therapytherapytherapytherapy: potassium chloride solution (15%) is added to deficit and
maintenance therapy: 1111mlmlmlml for eachfor eachfor eachfor each 100100100100 mlmlmlml solution to correct hypokalemia.
BBBB---- TreatmentTreatmentTreatmentTreatment of complicationsof complicationsof complicationsof complications
Painful oral lesionPainful oral lesionPainful oral lesionPainful oral lesion
Monilial stomatitisMonilial stomatitisMonilial stomatitisMonilial stomatitis Herpetic gingivostomatitisHerpetic gingivostomatitisHerpetic gingivostomatitisHerpetic gingivostomatitis HHHHerpanginaerpanginaerpanginaerpangina
Antifungal oral nystatin
(mucostatin) or oral
miconazol (daktarin oral gel)
for 10 days
SymptomaticSymptomaticSymptomaticSymptomatic oral analgesics
&antipyretics.
. Antiviral agents are not
indicated
SymptomaticSymptomaticSymptomaticSymptomatic
Hematology
Thalathemia majorThalathemia majorThalathemia majorThalathemia major
1111----Correction of anemiaCorrection of anemiaCorrection of anemiaCorrection of anemia 2222----Removal & prevention of iron ovRemoval & prevention of iron ovRemoval & prevention of iron ovRemoval & prevention of iron overload byerload byerload byerload by
iron chelating agentsiron chelating agentsiron chelating agentsiron chelating agents
• Packed RBCs transfusionPacked RBCs transfusionPacked RBCs transfusionPacked RBCs transfusion
-10-15 ml/ kg/ every 4-5 weeks to maintain
Hb level above 10 gm% (hypertransfusion)
• Folic acidFolic acidFolic acidFolic acid
To prevent megaloplastic changes in thebone marrow
DyferoxamineDyferoxamineDyferoxamineDyferoxamine:::: SC by a pump over 10hours 5-6 nights/ week
DeferiproneDeferiproneDeferiproneDeferiprone:::: oral chelating drug used
when complications of dyferoxamine occur
5/16/2018 Drugs in Pediatrics - slidepdf.com
http://slidepdf.com/reader/full/drugs-in-pediatrics 17/18
Drugs in Pediatrics NMT11
www.MedadTeam.org 17
3333---- SplenectomySplenectomySplenectomySplenectomy
IndicationsIndicationsIndicationsIndications -Hypersplenism
-Huge spleen causing pressure symptoms
TimingTimingTimingTiming Should not be done before 4 years to avoid sepsis
Care afterCare afterCare afterCare after
splenectomysplenectomysplenectomysplenectomy
-Vaccination against pneumococci, meningiococci & haemophilus
influenza b
-Long acting penicillin
4444---- Recent treatmentRecent treatmentRecent treatmentRecent treatment ::::
Bone marrow transplantation using marrow cells or peripheral stem cells
Induction of fetal Hb production by drugs e.g. L-carnitine
Gene therapy is under trial
Iron deficiency anemiaIron deficiency anemiaIron deficiency anemiaIron deficiency anemia
PreventionPreventionPreventionPrevention::::
- Adequate supply of iron to iron to iron to iron to mother mother mother mother during pregnancy
- Proper weaning: iron containing food iron containing food iron containing food iron containing food (green vegetables or meat products) should be given
to infant from age 6th month
- Ear Ear Ear Early ly ly ly diagnosis and treatment of the cause diagnosis and treatment of the cause diagnosis and treatment of the cause diagnosis and treatment of the cause e.g. Parasitic infestation-bleeding
Specific treatmentSpecific treatmentSpecific treatmentSpecific treatment:::: Iron therapyIron therapyIron therapyIron therapy
OralOralOralOral IntramuscularIntramuscularIntramuscularIntramuscularIndicationsIndicationsIndicationsIndications the usual route failure of oral route
PreparationsPreparationsPreparationsPreparations ferrous sulfate-ferrous gluconate iron dextran
DoseDoseDoseDose 6666mg/kg/daymg/kg/daymg/kg/daymg/kg/day 3 doses between meals 1111ml(ml(ml(ml(50505050mg)mg)mg)mg) in infant-2ml(100mg) in
young children
CourseCourseCourseCourse 4444----6666 weaksweaksweaksweaks after normalization of all
blood values to replete stores
3333 totototo5555 daysdaysdaysdays
Supportive treatmentSupportive treatmentSupportive treatmentSupportive treatment::::
Blood transfusion (packed red cells: 10101010 ml/kg slowlyml/kg slowlyml/kg slowlyml/kg slowly) in impending heart failure or when there
is serious infection
Immune thrombocytopenic purpura (ITP)Immune thrombocytopenic purpura (ITP)Immune thrombocytopenic purpura (ITP)Immune thrombocytopenic purpura (ITP)
Moderate and severeModerate and severeModerate and severeModerate and severe Number belowbelowbelowbelow 20202020,,,,000000000000 or mucous membrane bleeding
1111---- SteroidsSteroidsSteroidsSteroids 2222---- IV Ig or anti D:IV Ig or anti D:IV Ig or anti D:IV Ig or anti D:
ActionActionActionAction inhibit Ab synthesis & reduce capillary
fragility
bind antibodies before attacking
platelets
DoseDoseDoseDose 1-2 mg / kg /day 400 /kg over 4-8 hours
5/16/2018 Drugs in Pediatrics - slidepdf.com
http://slidepdf.com/reader/full/drugs-in-pediatrics 18/18
Drugs in Pediatrics NMT11
www.MedadTeam.org 18
DurationDurationDurationDuration until platelet count is normal or for 3
weeks which ever comes first
5 consecutive days , booster doses very
2-4 weeks may be needed
ExcellentExcellentExcellentExcellentresponseresponseresponseresponse
Rapid control of serious bleedingespecially postoperative in steroid
resistant cases. platelet count increase in
7-14 days after therapy
3333---- Transfusion therapyTransfusion therapyTransfusion therapyTransfusion therapy
4444---- SplenectomySplenectomySplenectomySplenectomy in chronic cases who are steroid resistant
5555---- ImmunosuppressiveImmunosuppressiveImmunosuppressiveImmunosuppressive e.g. azathioprine or cyclosporine in resistant cases who failed to respond
to splenectomy or relapse postoperatively
6666---- PlasmapharesisPlasmapharesisPlasmapharesisPlasmapharesis transient effect if all measures failed